Remicade (infliximab) is given by IV infusion, not a subcutaneous injection. Price varies a lot by country, payer, dose, and whether you use the brand or a biosimilar.
Rough US context (drug cost only, not infusion fees):
- Brand Remicade: typically a few thousand dollars per 100 mg vial. A common induction dose is around 210 mg per infusion, which often means 2–3 vials per infusion. Drug cost per infusion can be roughly in the ballpark of $3,000–$6,000, depending on exact dosing and vial sizes.
- Infusion center fees, physician/administration charges, pretreatment meds (e.g., acetaminophen, diphenhydramine, steroids), and monitoring add additional costs, so total per infusion can be higher (often several thousand dollars more).
- Induction course (three infusions at weeks 0, 2, and 6) could total well into the tens of thousands of dollars before insurance adjustments.
- Biosimilars (e.g., Inflectra, Renflexis) generally cost less than the brand, but prices vary.
Important caveats:
- Your actual out-of-pocket depends on your insurance, the provider, and any patient-assistance programs.
- Prices vary by country and even by pharmacy or infusion center.
If you want a more specific estimate, tell me:
- Your country/location
- Brand Remicade or a biosimilar
- Your approximate weight (to estimate mg per infusion)
- The dosing schedule you’re considering (induction vs. maintenance)
I can then give you a closer-range estimate and point you to price-check resources or patient-assistance options.